# Zhengya Chike

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhengya-chike

- Industry: Healthcare Specialists
- Headquarters: Shanghai, China
- Website: www.smartee.cn
- Total disclosed funding: $87M
- Latest round: Series D (Mar 1, 2022)
- Investors on record: 10

## About

Established in 2004 and based in Shanghai, china, Shanghai Smartee Denti-Technology Co., Ltd. is a dental services provider that focuses on digital orthodontic technology and invisible aligner research. The company has built an intelligent production base in Sichuan. In 2022, the company has more than 1,000 employees. Its R & D team has obtained more than 350 patents and completed over 430,000 cases of invisible orthodontic solution design. In 2015, KaVo Group took a stake in the company. In 2018, the company conducted joint research and development with UNC. In 2020, the company released the Diamond II multi-layer diaphragm. The company's products can be categorized into a series of orthodontic braces. They can realize the adjustment of upper and lower jaw, and improve various facial problems such as concave face, protruding face and deviated jaw. Its aligner materials contain features such as soft material and tear resistance.  The company generates revenue through the research and development of original digital invisible orthodontic technologies, as well as the medical design, manufacturing, and sales of customized invisible aligners.

## Funding rounds

- Series D, Mar 1, 2022, $79M — Taikang Investment, Zhangjiagang Industrial Capital Center, China Resources International Dispatching Xiamen Consumption Fund
- Series C, Mar 24, 2019 — China International Capital Corporation, CoStone Capital, YuanBio Venture, Neovision Capital, Qianhai Ark Capital
- Series B, Sep 1, 2017, $7.7M — China Orient Asset Management, YuanBio Venture, CD Capital

## Investors

- China Orient Asset Management — Series B
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series B, Series C
- CD Capital — Series B
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series C
- CoStone Capital (https://capitalatlas.ai/funds/costone-capital) — Series C
- Neovision Capital (https://capitalatlas.ai/funds/neovision-capital) — Series C
- Qianhai Ark Capital (https://capitalatlas.ai/funds/qianhai-ark-capital) — Series C
- Taikang Investment (https://capitalatlas.ai/funds/taikang-investment) — Series D
- Zhangjiagang Industrial Capital Center (https://capitalatlas.ai/funds/zhangjiagang-industrial-capital-center) — Series D
- China Resources International Dispatching Xiamen Consumption Fund — Series D